ArticleLeukemia & lymphoma2016

Combination of Pim kinase inhibitors and Bcl-2 antagonists in chronic lymphocytic leukemia cells.

Fabiola Cervantes-Gomez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.